BEGIN:VCALENDAR VERSION:2.0 X-WR-CALNAME;VALUE=TEXT:"First in Human" - The Potential of Neural Stem Cell-based Approaches for Treatment of Brain Disorders PRODID:-//Harvard events data//EN BEGIN:VEVENT UID:event_310131_0 SUMMARY:"First in Human" - The Potential of Neural Stem Cell-based Approaches for Treatment of Brain Disorders DESCRIPTION:

Guest speakers:
Ricardo Dolmetsch
Global Head of Neuroscience
Novartis Institutes for BioMedical Research and Department of Neurobiology, Stanford University

Kevin Eggan
Professor, Department of Stem Cell and Regenerative Biology, Harvard University

Fred Gage
Professor, Laboratory of Genetics
Salk Institute

Moderator:
Angela Messmer-Blust
Editor, Conferences, Webinars, and Special Content

A key challenge for translational efforts for nervous system disorders has been the development of animal and cellular models that appropriately model disease mechanisms and the complex biology of the human nervous system. With the advances in neurogenetics, we now have long lists of candidate genes for complex disorders such as schizophrenia and autism, but the path from genes to mechanisms has been more challenging. In recent years, new technologies in human-stem-cell-based approaches have come onto the scene as a potential breakthrough to surmount these translational hurdles. In the second of our series of webinars focused on translational neuroscience, we focus on the potential of groundbreaking pluripotent stem cell technologies to model “human” disease pathology and to serve as platforms for drug development.

LOCATION:Cell Press Webinar STATUS:CONFIRMED DTSTART:20141216T170000Z DTEND:20141216T180000Z END:VEVENT END:VCALENDAR